Issue 8, 2021

Using membrane perturbing small molecules to target chronic persistent infections

Abstract

After antibiotic treatment, a subpopulation of bacteria often remains and can lead to recalcitrant infections. This subpopulation, referred to as persisters, evades antibiotic treatment through numerous mechanisms such as decreased uptake of small molecules and slowed growth. Membrane perturbing small molecules have been shown to eradicate persisters as well as render these populations susceptible to antibiotic treatment. Chemotype similarities have emerged suggesting amphiphilic heteroaromatic compounds possess ideal properties to increase membrane fluidity and such molecules warrant further investigation as effective agents or potentiators against persister cells.

Graphical abstract: Using membrane perturbing small molecules to target chronic persistent infections

Article information

Article type
Review Article
Submitted
30 Apr 2021
Accepted
27 May 2021
First published
11 Jun 2021

RSC Med. Chem., 2021,12, 1312-1324

Author version available

Using membrane perturbing small molecules to target chronic persistent infections

C. L. Schrank, I. K. Wilt, C. Monteagudo Ortiz, B. A. Haney and W. M. Wuest, RSC Med. Chem., 2021, 12, 1312 DOI: 10.1039/D1MD00151E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements